Needle, subcutaneous injection/infusion port
Access comprehensive regulatory information for Needle, subcutaneous injection/infusion port in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Multigate Medical Devices Pty Ltd, manufactured by Promisemed Hangzhou Meditech Co Ltd in China. The device registration started on July 27, 2022.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
It is intended for subcutaneous injection of insulin in the treatment of diabetes.

